$CC

The Chemours Company Reports Second Quarter Results

Chemours Co (CC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 The Chemours Company Reports Second Quarter Results Wilmington, Del., August 4, 2026 – The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (“TSS”), Titanium Technol

Original reporting
Published Aug 4, 2026, 8:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 4, 2026, 8:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CC
Neutral
medium confidence
Mentioned
$CC
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CCNeutralMed
01

Why it matters

Traders can reassess valuation drivers around cash generation, leverage trajectory, and segment-level volume versus pricing, while monitoring how litigation-related reserves affect GAAP losses versus non-GAAP metrics.

02

Market read

Fresh quarterly numbers show net loss narrowing versus prior year, adjusted EBITDA near the prior-year level, and a sharp improvement in free cash flow and leverage, alongside ongoing volume softness in refrigerants.

03

What to watch

Volume headwinds in TSS Opteon blends and the Washington Works outage cost in APM could dominate the narrative even with pricing increases and leverage improvement.

Relevance 7/10Novelty 7/10Timing: after-hours filing on Aug 4, 2026
AlphAI · Earnings readCC · second quarter 2026 · ended June 30, 2026

Second quarter Net Sales were $1,591 million, Adjusted EBITDA was $247 million, and Net Loss attributable to Chemours was ($274) million.

→Mixed quarter

Pricing, sequential sales growth, improved operating cash flows, and lower net leverage were offset by lower year-over-year sales, Adjusted EBITDA, Adjusted Net Income, and an ongoing GAAP net loss.

Revenue
$1.59B
(1%) y/y · 15% q/q
Thermal & Specialized Solutions
$591M
(1%) y/y · 4% q/q
EPS · non-GAAP
$0.42
(31%) y/y · 740% q/q

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Net SalesGAAP$1.59B15%(1%)
Net Income (Loss) attributable to ChemoursGAAP($274) million(845%)28%
Earnings (Loss) Per ShareGAAP($1.81)(853%)28%
Adjusted Net Incomenon-GAAP$64M700%(30%)
Adjusted EPSnon-GAAP$0.42740%(31%)
Adjusted EBITDAnon-GAAP$247M46%(5%)
Free Cash Flow Conversionnon-GAAP46%––
Operating cash flowsGAAP$158M––
Corporate Expensesother$42M––
Opteon™ Refrigerants Net Salesother$337M8%(10%)
Freon™ Refrigerants Net Salesother$150M(7%)22%
Foam, Propellants & Other (FP&O) Net Salesother$104M12%5%
TSS Adjusted EBITDAnon-GAAP$213M12%3%
TSS Adjusted EBITDA Marginnon-GAAP36%3 ppts1 ppts
TiO 2 Pigment Net Salesother$639M18%2%
Minerals Net Salesother$22M22%(21%)
TT Adjusted EBITDAnon-GAAP$48M167%2%
TT Adjusted EBITDA Marginnon-GAAP7%4 ppts0 ppts
Advanced Materials Net Salesother$184M29%(14%)
Performance Solutions Net Salesother$142M42%8%
APM Adjusted EBITDAnon-GAAP$26M420%(48%)
APM Adjusted EBITDA Marginnon-GAAP8%6 ppts(6) ppt
Other Non-Reportable Segment Net Salesother$13M––
Other Non-Reportable Segment Adjusted EBITDAnon-GAAP$2M––

Segments

SegmentRevenueq/qy/y
Thermal & Specialized SolutionsLower stationary AC aftermarket refrigerant sales of TSS Opteon™ blends in North America compared with elevated Q2 2025 demand were partly offset by higher Freon™ prices, primarily in automotive applications.$591M4%(1%)
Titanium TechnologiesA 2% increase in global pricing and a 1% currency tailwind more than offset a 2% decline in global volumes.$661M18%1%
Advanced Performance MaterialsThe APM SPS Capstone™ line closure completed in the third quarter of 2025 reduced volumes, while Performance Solutions benefited from order book strength and high-value specialty products serving data center and semiconductor end markets.$326M34%(6%)
Other Non-Reportable SegmentThe segment includes the Performance Chemicals and Intermediates business.$13M––

Capital returns

  • During the quarter, the Company paid down €230 million of the outstanding tranche of the B-3 Euro-denominated Term Loan due August 2028, using a mixture of proceeds from the previously announced Kuan Yin land sale and organic cash.

What drove it

  • Pricing increased across all three segments, including price increases in TT.
  • Total Net Sales volume declined 4%, partially offset by a 2% increase in price and a 1% currency tailwind.
  • TSS Adjusted EBITDA increased on higher pricing and the timing of certain costs in the quarter.
  • TT pricing increased across all regions.
  • APM Performance Solutions Net Sales grew 8% year-over-year, supported by order book strength and momentum in high-value specialty products serving data center and semiconductor end markets.
  • APM sequential volumes reflected more normalized operations at the Washington Works site.

Concerns

  • Total Net Sales declined 1% year-over-year as a 4% volume decrease exceeded pricing and currency benefits.
  • Adjusted EBITDA declined 5% year-over-year and Adjusted Net Income declined 30% year-over-year.
  • APM Adjusted EBITDA decreased 48% year-over-year and Adjusted EBITDA Margin declined to 8% from 14%.
  • The second-quarter GAAP loss included legal and environmental reserves related to the announced settlement with the EPA and WVDEP as well as ongoing litigation, and corresponding tax impacts.
  • TT global volumes declined 2% year-over-year, with lower TiO 2 sales across key end markets except Asia excluding China and Latin America.

What to watch

  • Further TiO 2 pricing actions and their effect on TT pricing, volumes, and inflation-related costs.
  • TSS aftermarket refrigerant demand following the elevated Q2 2025 initial channel fill associated with the stationary technology AC transition under the U.S. AIM Act.
  • APM recovery following the resolved Washington Works outage and the impact of the SPS Capstone™ line closure.
  • Performance Solutions order book strength and sales into data center and semiconductor end markets.
  • Further debt repayments anticipated in 2026 and progress toward sustaining leverage below 3x.

Balance sheet and cash flow

  • As of June 30, 2026, consolidated gross debt was $3.9 billion.
  • Debt, net of $671 million in unrestricted cash and cash equivalents, was $3.2 billion.
  • Net leverage ratio was approximately 4.4x on a trailing twelve-month Adjusted EBITDA basis.
  • Total liquidity was $1.6 billion, comprised of $671 million in unrestricted cash and cash equivalents and $953 million of revolving credit facility capacity, net of outstanding letters of credit.
  • Operating cash flows for the second quarter of 2026 were $158 million, compared to $93 million in the prior-year quarter.
  • Free Cash Flows improved 128% year-over-year.

Analysis

Chemours reported second-quarter Net Sales of $1,591 million, down 1% year-over-year, while Adjusted EBITDA declined 5% to $247 million. A 4% volume reduction was only partly offset by a 2% price increase and a 1% currency tailwind. The primary consolidated volume pressures were lower TSS Opteon™ blends aftermarket refrigerant sales following elevated prior-year channel-fill demand and lower APM volumes associated with the SPS Capstone™ line closure.

The segment mix was uneven. TSS sales declined 1%, but Adjusted EBITDA increased 3% to $213 million and margin improved to 36%, supported by pricing and cost timing. TT sales grew 1% and Adjusted EBITDA rose to $48 million as pricing and currency benefits outweighed lower global volumes. TT also recorded 18% sequential sales growth, driven by higher global volumes and price. APM was the principal earnings drag: sales fell 6%, Adjusted EBITDA fell 48% to $26 million, and margin declined to 8%, reflecting the Capstone closure and costs from the Washington Works outage.

Performance Solutions was a constructive element within APM, with Net Sales up 8% year-over-year and 42% sequentially. The company cited order book strength and demand for high-value specialty products serving data center and semiconductor end markets. Pricing strength across all three segments also mitigated the effect of lower volumes, while the approximately 5% year-to-date TiO 2 price increase in Net Sales underscores the role of TT pricing actions in the period.

GAAP results remained materially affected by legal and environmental matters. Net Loss attributable to Chemours was ($274) million, versus ($380) million in the prior-year quarter, with the current-year loss including reserves related to the announced EPA and WVDEP settlement and ongoing litigation, plus corresponding tax impacts. Adjusted Net Income declined to $64 million from $91 million, which the company attributed primarily to additional income tax impacts related to Kuan Yin property sales completed during the quarter.

Cash generation and debt reduction improved. Operating cash flows increased to $158 million from $93 million, Free Cash Flows improved 128% year-over-year, and Free Cash Flow Conversion was 46%. Chemours paid down €230 million of its B-3 Euro-denominated Term Loan, reported $3.9 billion of gross debt and approximately 4.4x net leverage, and stated that it anticipates further debt repayments in 2026. No numerical forward guidance was included in the provided filing text.

Management, verbatim

Our second quarter results reflect disciplined execution across our portfolio, with Adjusted EBITDA near the high end of our guidance range and Free Cash Flows above our expectations despite a dynamic macroeconomic environment.

Denise Dignam, Chemours President and CEO

Progress on pricing actions in Titanium Technologies to drive value, and increased sales in APM’s high-value Performance Solutions portfolio supporting our momentum serving data center and semiconductor applications, and continued traction in our liquid cooling solutions, highlight our efforts to drive commercial excellence and growth.

Denise Dignam, Chemours President and CEO

Not in the filing

stated, not guessed
  • Numerical forward guidance for revenue, gross margin, operating expenses, tax rate, Adjusted EBITDA, earnings, free cash flow, or other metrics
  • Previous-period outlook for comparison with actual results
  • GAAP gross profit and gross margin
  • GAAP operating income or loss and operating margin
  • GAAP tax rate
  • Absolute Free Cash Flow amount and prior-year Free Cash Flow amount
  • Share repurchases and dividend declarations or payments
  • Prior-year and prior-quarter comparisons for Other Non-Reportable Segment Net Sales and Adjusted EBITDA
  • Prior-year and prior-quarter amounts for Corporate Expenses

AlphAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

The filing is Chemours’ SEC Form 8-K reporting Q2 2026 results of operations and financial condition, with segment detail for TSS and Titanium Technologies and commentary on pricing actions and litigation progress.

Company-level read

Ticker impact

$CCNeutralMedium confidence
Context

Chemours reported Q2 2026 results, including net loss of $274M, adjusted EBITDA of $247M, and free cash flow up 128% YoY.

Expected impact

Likely modest, two-sided reaction depending on how investors weigh improved free cash flow and leverage versus continued net losses and litigation-related reserve impacts.

Evidence & confidence

This is a primary earnings release with multiple quantified items: FCF conversion 46%, net leverage down to 4.4x, and segment volume/pricing drivers, but it does not include explicit forward guidance in the provided text.

Market effects

Updates demand and pricing dynamics in TiO2 and refrigerants, which can influence sentiment across specialty chemicals and industrial materials pricing power.

Limited direct regional read-through; primarily US-listed company fundamentals.

Global pricing actions (TiO2) and refrigerant aftermarket volumes can affect broader industrial chemical supply-demand expectations.

Counterpoint

Improved free cash flow may be partly offset by litigation reserve timing and one-off tax impacts, so cash strength may not fully translate into sustainable earnings power.

Key entities

  • The Chemours Company

    NYSE-listed specialty chemicals producer reporting Q2 2026 financial results and cash/leverage progress.

  • Denise Dignam

    CEO quoted on disciplined execution, pricing actions, APM momentum, and balance sheet progress.

  • U.S. AIM Act

    Stationary technology AC transition referenced as a driver of elevated aftermarket demand in Q2 2025.

  • EPA and WVDEP

    Referenced in connection with legal and environmental reserves related to an announced settlement.

Every CC earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$CCHigh

Why is Chemours stock sliding today?

Chemours (CC) stock fell 2.3% in pre-market trading after Mizuho downgraded it to Neutral and cut its price target to $15. RBC also downgraded it to Sector Perform, reducing its target to $14. Both analysts cited concerns over slower earnings growth and weak demand in key markets. The stock has lost over 40% in six months, trading near its 52-week low.

$CCMed

Mizuho downgrades Chemours stock rating on refrigerants delay

Mizuho downgraded Chemours (NYSE:CC) to Neutral from Outperform, lowering its price target to $15 from $18. The downgrade reflects slower-than-expected earnings growth from new refrigerants and concerns about titanium dioxide pigment market stability. Chemours' stock is down over 41% in the past six months, trading at $13.20. The company reported mixed Q2 2026 results, missing earnings and revenue estimates, and settled PFAS-related claims with North Carolina.

$CCHigh

Chemours falls as RBC downgrades stock on persistent TiO2 weakness

Chemours Co (CC) shares dropped 2.5% premarket after RBC downgraded it to Sector Perform, citing weak TiO2 demand and reduced growth expectations. RBC cut its price target to $14 from $22 and lowered EBITDA estimates for Q3 and FY26-FY27, citing macro pressures and project delays. The analyst sees limited near-term upside and a fully valued stock at current levels.

$CCMedAI 8/10

Corporations Are Dodging Accountability for PFAS Contamination Around the Globe

Chemours, a chemical company, has been linked to PFAS contamination in the Cape Fear River, North Carolina, affecting drinking water and health. The state reached a $590M settlement with Chemours for damages. PFAS contamination has also been reported near Chemours' facilities worldwide, raising concerns about global environmental and health impacts. Chemours inherited cleanup liabilities from its former parent company, DuPont, after a 2015 spin-off.